Atlas Trials

Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma

Clinical trial NCT01045941 · WITHDRAWN

Trial details

NCT number
NCT01045941
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Neoplasms
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.